Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on May 27, 2021 4:19pm
244 Views
Post# 33280055

Beyond Canada

Beyond Canada

Considering the manipulation today there was every chance THRM could have been up a penny instead of down one. Having said that I, for one, am glad to see Asia, Brazil, Columbia and Europe as potential jurisdictions and focus for AcuVid. HC has not approved a single rapid antigen point of care covid test device since February 19, 2021. I'm not sure why Rob Fia, or anyone else for that matter, would be interested in jumping on this treadmill. 

Even SONA, trying to resurrect itself with some recent NRs is nowhere to be found. As articles as recent as today suggest it could take until the end of the year for all Canadians ( that want them) to be fully vaccinated, the developing world will, sadly, remain at the end of the queue. Hopefully AcuVid can be the source of some sense of normal for those waiting for the vaccines.

 

<< Previous
Bullboard Posts
Next >>